Key terms

About EVGN

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest EVGN news

Apr 30 5:33pm ET Evogene Ltd. Announces Upcoming Annual Meeting Apr 02 1:18pm ET Evogene management to meet virtually with Lake Street Apr 02 7:57am ET Evogene’s New Venture Targets Sustainable Protein Market Apr 01 8:55am ET Evogene (EVGN) Receives a Buy from Lake Street Mar 28 9:30pm ET Evogene Ltd. Announces $7.3 Million Share Sale Plan Mar 20 9:27am ET Evogene Ltd. Faces Nasdaq Compliance Challenge Mar 20 9:02am ET Evogene receives Nasdaq Minimum Bid Price notification Mar 19 9:03am ET Bayer, Lavie Bio continue biofungicides validation Mar 07 7:09am ET Evogene reports Q4 EPS (13c), consensus (14c) Mar 05 8:56am ET Lake Street Sticks to Their Buy Rating for Evogene (EVGN) Mar 01 7:46am ET Buy Rating Affirmed on Evogene’s Growth Potential and Commercial Ramp-Up in 2024 Mar 01 7:05am ET Evogene files $200M mixed securities shelf Feb 28 7:19am ET Lavie Bio secures second $2.5M advance payment from Corteva Feb 23 11:04am ET Biotech Alert: Searches spiking for these stocks today Feb 21 7:15am ET Evogene’s AgPlenus announces licensing, collaboration agreement with Bayer Feb 20 8:45am ET Evogene (EVGN) Gets a Buy from Lake Street Feb 20 7:20am ET Evogene’s Lavie Bio partners with Syngenta Crop Protection Feb 06 7:14am ET Evogene and Verb Biotics partner in probiotic innovation

No recent press releases are available for EVGN

EVGN Financials

1-year income & revenue

Key terms

EVGN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

EVGN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms